Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.

Kalil, Andre C

Kalil, Andre C.

Kalil AC; Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.

JAMA ; 323(19): 1897-1898, 2020 May 19.

Article in English | MEDLINE | ID: covidwho-1453468

Subject(s)

Betacoronavirus; Compassionate Use Trials; Coronavirus Infections/drug therapy; Off-Label Use; Pneumonia, Viral/drug therapy; Randomized Controlled Trials as Topic; Antiviral Agents/adverse effects; Antiviral Agents/therapeutic use; COVID-19; Hemorrhagic Fever, Ebola/drug therapy; Humans; Pandemics; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Randomized Controlled Trials as Topic / Coronavirus Infections / Off-Label Use / Compassionate Use Trials / Betacoronavirus Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: JAMA Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google